Estrogen (E2) through its nuclear receptor alpha (ERα) and beta (ERβ), activates several pathways involved in lung carcinogenesis, including cell proliferation, tumor growth, antiapoptotic signals, angiogenesis, migration, and metastasis (25–27). Here, ESR2 is linked to neoplasm.